Incidence of pelvic inflammatory disease in clinical trials with cu-7 (intrauterine copper contraceptive): A statistical analysis
- 1 February 1983
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 27 (2) , 111-122
- https://doi.org/10.1016/0010-7824(83)90082-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Contraception and the etiology of pelvic inflammatory disease: New perspectivesAmerican Journal of Obstetrics and Gynecology, 1980
- Intrauterine contraceptive device use and pelvic inflammatory diseaseAmerican Journal of Obstetrics and Gynecology, 1980
- The intrauterine contraceptive device and acute salpingitisAmerican Journal of Obstetrics and Gynecology, 1979
- THE RISK OF PELVIC INFLAMMATORY DISEASE IN WOMEN USING INTRAUTERINE CONTRACEPTIVE DEVICES AS COMPARED TO NON-USERSThe Lancet, 1976
- Intrauterine devices and acute pelvic inflammatory diseaseJAMA, 1976
- ASSOCIATION OF THE INTRAUTERINE DEVICE AND PELVIC INFLAMMATORY DISEASE: A RETROSPECTIVE PILOT STUDYAmerican Journal of Epidemiology, 1974
- INTRAUTERINE CONTRACEPTION USING THE COPPER-SEVEN DEVICEThe Lancet, 1972
- The first year of clinical experience with the Copper T intrauterine contraceptive system in the United States and CanadaContraception, 1972
- Contraception through the use of intrauterine metals. I. Copper as an adjunct to the “T” deviceAmerican Journal of Obstetrics and Gynecology, 1971
- Metallic copper as an intrauterine contraceptive adjunct to the “T” deviceAmerican Journal of Obstetrics and Gynecology, 1969